Novel Discoveries of the Relationship Between the Vitreous Zonule and the Anterior Segment Characteristics in Eyes With Primary Angle-Closure Disease.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
01 12 2022
Historique:
entrez: 15 12 2022
pubmed: 16 12 2022
medline: 20 12 2022
Statut: ppublish

Résumé

To investigate the presence of the vitreous zonule (VZ) in different subtypes of primary angle-closure disease (PACD) and to explore the relationship between VZ and anterior chamber angle characteristics. Patients with clinical diagnoses of acute primary angle-closure (PAC)/PAC glaucoma (APAC[G]) or chronic PAC/PAC glaucoma (CPAC[G]) and healthy subjects were enrolled. A total of 300 eyes of 180 subjects were included. Anterior segment parameters and the presence of the VZ were assessed by ultrasound biomicroscopy. The presence of VZ was compared among different subtypes of PACD. Anterior segment parameters were compared between eyes in vitreous zonule group (VZG) and no vitreous zonule group (NVZG). Logistic regression analysis was conducted to identify factors associated with the presence of VZ. APAC(G) eyes had lower VZ presence compared to the fellow eyes of APAC(G) (P < 0.001). VZ was more likely to be seen in the eyes of healthy subjects and PAC suspect than in the eyes of PAC and PAC glaucoma (PACG) (P < 0.05). NVZG had shorter angle opening distance 500/750 (P < 0.001), smaller trabecular iris angle 500/750 (P < 0.001), smaller trabecular-iris space area 500/750 (P < 0.001), smaller trabecular-ciliary angle (P = 0.009), smaller iris area (P = 0.010), and greater lens vault (P = 0.004) compared to VZG. Greater lens vault (LV) was independently associated with absence of VZ (odds ratio = 0.253; 95% confidence interval, 0.109-0.586; P = 0.001). VZ was less likely to be observed in PAC/PACG eyes. PACD eyes with less VZ had narrower angle, more anteriorly rotated ciliary body, and greater LV.

Identifiants

pubmed: 36520454
pii: 2783926
doi: 10.1167/iovs.63.13.16
pmc: PMC9769030
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

16

Commentaires et corrections

Type : ErratumIn

Références

Ophthalmic Physiol Opt. 2016 Jan;36(1):21-32
pubmed: 26769326
Ophthalmology. 2010 Oct;117(10):1967-73
pubmed: 20541809
J Glaucoma. 2015 Mar;24(3):233-7
pubmed: 25055211
Invest Ophthalmol Vis Sci. 2014 May 20;55(6):3646-50
pubmed: 24845639
Invest Ophthalmol Vis Sci. 2013 Jul 26;54(7):5049-58
pubmed: 23745005
Optom Vis Sci. 2001 Jun;78(6):417-24
pubmed: 11444631
Ophthalmology. 2014 Nov;121(11):2081-90
pubmed: 24974815
Br J Ophthalmol. 2002 Feb;86(2):238-42
pubmed: 11815354
J Glaucoma. 2011 Jun-Jul;20(5):315-8
pubmed: 20577108
Arch Ophthalmol. 1993 Sep;111(9):1263-9
pubmed: 8363470
Invest Ophthalmol Vis Sci. 2019 Apr 1;60(5):1801-1812
pubmed: 31038661
Invest Ophthalmol Vis Sci. 2013 Jul 26;54(7):5035-48
pubmed: 23745002
Br J Ophthalmol. 1964 Oct;48:544-50
pubmed: 14221777
Prog Retin Eye Res. 2017 Mar;57:26-45
pubmed: 28039061
PLoS One. 2018 Feb 15;13(2):e0193006
pubmed: 29447247
Clin Exp Ophthalmol. 2012 Nov;40(8):792-801
pubmed: 22594402
Am J Ophthalmol. 2013 Apr;155(4):664-673, 673.e1
pubmed: 23246271
Br J Ophthalmol. 2006 Mar;90(3):262-7
pubmed: 16488940
Semin Ophthalmol. 2018;33(5):595-601
pubmed: 29185835
Invest Ophthalmol Vis Sci. 2021 Nov 1;62(14):6
pubmed: 34730791
Ophthalmology. 1998 Nov;105(11):2091-8
pubmed: 9818611
Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1554-64
pubmed: 19815737
J Glaucoma. 2019 Dec;28(12):1048-1053
pubmed: 31633619
Am J Ophthalmol. 2009 Nov;148(5):657-669.e1
pubmed: 19878757

Auteurs

Kun Lv (K)

Department of Ophthalmology, Peking University People's Hospital, Beijing, China.
Eye Diseases and Optometry Institute, Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, College of Optometry, Peking University Health Science Center, Beijing, China.

Zhiqiao Liang (Z)

Department of Ophthalmology, Peking University People's Hospital, Beijing, China.
Eye Diseases and Optometry Institute, Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, College of Optometry, Peking University Health Science Center, Beijing, China.

Kangyi Yang (K)

Department of Ophthalmology, Peking University People's Hospital, Beijing, China.
Eye Diseases and Optometry Institute, Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, College of Optometry, Peking University Health Science Center, Beijing, China.

Xuanzhu Chen (X)

Department of Ophthalmology, Peking University People's Hospital, Beijing, China.
Eye Diseases and Optometry Institute, Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, College of Optometry, Peking University Health Science Center, Beijing, China.

Yao Ma (Y)

Department of Ophthalmology, Peking University People's Hospital, Beijing, China.
Eye Diseases and Optometry Institute, Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, College of Optometry, Peking University Health Science Center, Beijing, China.

Huijuan Wu (H)

Department of Ophthalmology, Peking University People's Hospital, Beijing, China.
Eye Diseases and Optometry Institute, Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, College of Optometry, Peking University Health Science Center, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH